< 1 minute read
Nov. 26, 2021
Onametostat: A Selective Orally Pseudo-Irreversible PRMT5 Inhibitor
JNJ-64619178
pseudo-irreversible methyltransferase inh. oral, phase I, cancer from adenosine derivative library + opt. Molecular Cancer Therapeutics Janssen R&D